APA (7th ed.) Citation

BM, H., S, S., M, A., I, A., MS, A., M, G., . . . M, S. (2026). Efficacy and safety of extended-interval dosing of natalizumab in multiple sclerosis: A systematic review and meta-analysis with subgroup evaluation. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 47(8), . https://doi.org/10.1007/s10072-026-09211-0

Chicago Style (17th ed.) Citation

BM, Hammadeh, Sameer S, Alnajjar M, Abu-Issa I, Alhallaq MS, Ghazi M, Badr A, and Shawawrah M. "Efficacy and Safety of Extended-interval Dosing of Natalizumab in Multiple Sclerosis: A Systematic Review and Meta-analysis with Subgroup Evaluation." Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 47, no. 8 (2026). https://doi.org/10.1007/s10072-026-09211-0.

MLA (9th ed.) Citation

BM, Hammadeh, et al. "Efficacy and Safety of Extended-interval Dosing of Natalizumab in Multiple Sclerosis: A Systematic Review and Meta-analysis with Subgroup Evaluation." Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, vol. 47, no. 8, 2026, https://doi.org/10.1007/s10072-026-09211-0.